The high expression of the Ca2+ pathway transcription factor NFATc2 is considered to be a new regulator for lung cancer to initiate cell phenotype, and high NFATc2 expression predicted poor tumor differentiation, adverse recurrence-free, and cancer-specific overall survivals in human lung cancers [19]. This evidence concerns the gene NFATC2 and cancer.